Hi-Clearance Inc
Hi-Clearance Inc provides medical equipment, supplies, and distribution services within the healthcare sector.
Business. Hi-Clearance Inc (1788.TWO) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm is listed on the Taiwan Premium Board (TPEx) and engages in the sale of medical products. Specific details regarding operating segments, headquarters location, and geographic revenue mix are not available in the provided data.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Hi-Clearance Inc (1788.TWO) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm is listed on the Taiwan Premium Board (TPEx) and engages in the sale of medical products. Specific details regarding operating segments, headquarters location, and geographic revenue mix are not available in the provided data.
Hi-Clearance Inc maintains a conservative capital structure with a debt-to-equity ratio of 0.34, well below the industry median of 0.65, indicating a strong equity position relative to its liabilities. The company's liquidity position is characterized as medium, with a current ratio of 1.72, suggesting it can cover its short-term obligations but with limited excess capacity. Free cash flow of TWD 116.24 million supports operational flexibility, though cash and equivalents of TWD 89.56 million are modest relative to total liabilities.
Profitability metrics show a return on equity (ROE) of 12.08% and a return on assets (ROA) of 7.25%, both exceeding the industry median of 9.5% and 5.8%, respectively. This suggests Hi-Clearance Inc is generating returns above the industry average, driven by strong gross and operating margins. The company's operating income of TWD 422.16 million and net income of TWD 368.51 million reflect efficient cost management and pricing power in its core markets.
The company's revenue is concentrated in a single disclosed segment, with no geographic breakdown provided in the latest financials. This lack of diversification may expose the company to regional or sector-specific risks, though the healthcare services and equipment industry is generally stable and less cyclical.
Looking ahead, the company is projected to maintain a steady growth trajectory, with revenue expected to increase by 4.2% in the current fiscal year and 3.8% in the following year. This growth is supported by a consistent capital expenditure strategy, with CAPEX of TWD -139.84 million in the latest period, indicating a focus on cost control and asset optimization.
Risk factors include a liquidity risk due to negative net cash after subtracting total debt, which could limit the company's ability to respond to unexpected capital needs. The dilution risk is assessed as low, with no significant dilution sources identified in the latest filings. However, the company's reliance on a single business segment and limited geographic diversification could pose operational and market concentration risks.
Recent events include the filing of the latest financial report, which disclosed strong operating cash flow of TWD 389.54 million and a net income margin of 8.61%. No major regulatory or legal issues were reported in the latest filings, and the company has not issued any new shares in the past 12 months.
- Hi-Clearance Inc maintains a conservative capital structure with a debt-to-equity ratio of 0.34, below the industry median.
- The company's ROE of 12.08% and ROA of 7.25% indicate strong profitability relative to industry peers.
- Revenue is concentrated in a single business segment, with no geographic diversification disclosed.
- The company is projected to grow revenue by 4.2% in the current fiscal year and 3.8% in the following year.
- Liquidity risk is present due to negative net cash after subtracting total debt, but dilution risk is assessed as low.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- Hi-Clearance Inc Market data — financials · 2026-05-26